Evidence map›Paper›PMID 28944802›Full record

ArticleMetallomics : integrated biometal science2017

Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain.

Sian Genoud, Blaine R Roberts, Adam P Gunn, Glenda M Halliday, Simon J G Lewis, Helen J Ball, Dominic J Hare, Kay L Double

Open access · bronzeAbstract read
In one paragraph

Article in Metallomics : integrated biometal science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 2 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 2 syntheses or guidelines pooled it, 121 citations in OpenAlex.

  1. Pooled it
  2. Are high copper levels related to Alzheimer's and Parkinson's diseases? A systematic review and meta-analysis of articles published between 2011 and 2022.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2024
    Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Copper-mediated neurotoxicity and genetic vulnerability in the background of neurodegenerative diseases in C. elegans.Toxicological sciences : an official journal of the Society of Toxicology · 2024
    Article
  19. Metal ions overloading and cell death.Cell biology and toxicology · 2024
    Review
  20. Ferroptosis-A Shared Mechanism for Parkinson's Disease and Type 2 Diabetes.International journal of molecular sciences · 2024
    Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Sian GenoudDiscipline of Biomedical Science and Brain and Mind Centre, Sydney Medical School, The University of Sydney, Camperdown, NSW 2006, Australia. kay.double@sydney.edu.au.ORCID 0000-0001-8787-4541
Blaine R RobertsThe Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3052, Australia. dominic.hare@florey.edu.au.
Adam P GunnThe Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3052, Australia. dominic.hare@florey.edu.au.
Glenda M HallidayDiscipline of Biomedical Science and Brain and Mind Centre, Sydney Medical School, The University of Sydney, Camperdown, NSW 2006, Australia. kay.double@sydney.edu.au and Neuroscience Research Australia, Randwick, NSW 2031, Australia and School of Medical Sciences, University of New South Wales, NSW 2052, Australia.
Simon J G LewisDiscipline of Biomedical Science and Brain and Mind Centre, Sydney Medical School, The University of Sydney, Camperdown, NSW 2006, Australia. kay.double@sydney.edu.au and Healthy Brain Ageing Program, University of Sydney, NSW 2006, Australia and Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.
Helen J BallBosch Institute, University of Sydney, Camperdown, NSW 2006, Australia.
Dominic J HareThe Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3052, Australia. dominic.hare@florey.edu.au and Elemental Bio-imaging Facility, University of Technology Sydney, Broadway, NSW 2007, Australia and Department of Pathology, The University of Melbourne, Parkville, VIC 3052, Australia.ORCID 0000-0002-5922-7643
Kay L DoubleDiscipline of Biomedical Science and Brain and Mind Centre, Sydney Medical School, The University of Sydney, Camperdown, NSW 2006, Australia. kay.double@sydney.edu.au.
The University of Sydney · AUThe University of Melbourne · AUUniversity of Technology Sydney · AU

Funding

Brain Tissue Resource Centre for Alcohol ResearchR28AA012725 · NIAAA · UNIVERSITY OF SYDNEY · PI Greg Trevor Sutherland · 2012 to 2026
$7.0M
BRAIN TISSUE RESOURCE CENTER FOR ALCOHOL RESEARCHR24AA012725 · NIAAA · UNIVERSITY OF SYDNEY · PI KRIL, JILLIAN JUNE · 2000 to 2011
$2.2M
NIAAA NIH HHS R24 AA012725NIAAA NIH HHS R28 AA012725
6 · The paper itself

Abstract

Elevated iron and decreased copper levels are cardinal features of the degenerating substantia nigra pars compacta in the Parkinson's disease brain. Both of these redox-active metals, and fellow transition metals manganese and zinc, are found at high concentrations within the midbrain and participate in a range of unique biological reactions. We examined the total metal content and cellular compartmentalisation of manganese, iron, copper and zinc in the degenerating substantia nigra, disease-affected but non-degenerating fusiform gyrus, and unaffected occipital cortex in the post mortem Parkinson's disease brain compared with age-matched controls. An expected increase in iron and a decrease in copper concentration was isolated to the soluble cellular fraction, encompassing both interstitial and cytosolic metals and metal-binding proteins, rather than the membrane-associated or insoluble fractions. Manganese and zinc levels did not differ between experimental groups. Altered Fe and Cu levels were unrelated to Braak pathological staging in our cases of late-stage (Braak stage V and VI) disease. The data supports our hypothesis that regional alterations in Fe and Cu, and in proteins that utilise these metals, contribute to the regional selectively of neuronal vulnerability in this disorder.

Indexed as

AdultAgedAged, 80 and overBrainCase-Control StudiesCopperFemaleHumansIronMaleManganeseMiddle AgedParkinson DiseaseSubcellular FractionsZincCopperIronManganeseZinc

Identifiers

PMID28944802
PMCPMC5647261
OpenAlexW2755408424

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.